Craig Morrell
Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Blood Platelets | 12 | 2005 | 67 |
Why?
| Platelet Activation | 6 | 2008 | 18 |
Why?
| Malaria, Cerebral | 3 | 2008 | 3 |
Why?
| Exocytosis | 13 | 2003 | 15 |
Why?
| Platelet Factor 4 | 2 | 2008 | 10 |
Why?
| Endothelium, Vascular | 7 | 2003 | 139 |
Why?
| Inflammation | 4 | 2005 | 208 |
Why?
| Graft Rejection | 5 | 2007 | 59 |
Why?
| Vesicular Transport Proteins | 7 | 2003 | 12 |
Why?
| Thrombosis | 4 | 2005 | 105 |
Why?
| Mice | 20 | 2000 | 623 |
Why?
| Vascular Diseases | 2 | 2005 | 60 |
Why?
| Leukocytes | 5 | 2005 | 94 |
Why?
| Animals | 25 | 2000 | 1031 |
Why?
| Glutamic Acid | 2 | 2008 | 66 |
Why?
| Receptors, Glutamate | 1 | 2010 | 13 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2003 | 12 |
Why?
| Interferon-beta | 1 | 2011 | 26 |
Why?
| Immunologic Factors | 1 | 2011 | 46 |
Why?
| Nitric Oxide | 9 | 2003 | 85 |
Why?
| Blood Coagulation | 1 | 2010 | 57 |
Why?
| Mice, Inbred C57BL | 11 | 2000 | 318 |
Why?
| Endothelial Cells | 6 | 2004 | 80 |
Why?
| Receptors, Kainic Acid | 1 | 2009 | 3 |
Why?
| Transplantation Immunology | 2 | 2007 | 19 |
Why?
| Plasmodium falciparum | 1 | 2008 | 9 |
Why?
| Host-Pathogen Interactions | 1 | 2008 | 15 |
Why?
| Major Histocompatibility Complex | 1 | 2008 | 23 |
Why?
| Transplantation | 1 | 2007 | 4 |
Why?
| Monocytes | 1 | 2010 | 124 |
Why?
| Isoantibodies | 1 | 2008 | 25 |
Why?
| Receptors, AMPA | 1 | 2008 | 17 |
Why?
| Cell Communication | 2 | 2008 | 72 |
Why?
| Weibel-Palade Bodies | 7 | 2003 | 2 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2009 | 66 |
Why?
| Cardiovascular Diseases | 1 | 2010 | 127 |
Why?
| Reactive Oxygen Species | 1 | 2008 | 112 |
Why?
| Cytoplasmic Granules | 2 | 2005 | 30 |
Why?
| Brain | 2 | 2008 | 305 |
Why?
| Peritonitis | 1 | 2005 | 28 |
Why?
| Humans | 27 | 2000 | 1856 |
Why?
| Dog Diseases | 1 | 2002 | 8 |
Why?
| N-Ethylmaleimide-Sensitive Proteins | 7 | 2003 | 2 |
Why?
| Gallbladder Neoplasms | 1 | 2002 | 7 |
Why?
| Carcinoid Tumor | 1 | 2002 | 20 |
Why?
| Mice, Knockout | 4 | 2008 | 265 |
Why?
| Inflammation Mediators | 3 | 2010 | 56 |
Why?
| T-Lymphocytes | 3 | 2007 | 182 |
Why?
| Receptors, CXCR3 | 2 | 2008 | 5 |
Why?
| Platelet Aggregation Inhibitors | 2 | 2010 | 48 |
Why?
| Skin Transplantation | 2 | 2008 | 39 |
Why?
| Atherosclerosis | 2 | 2008 | 29 |
Why?
| Mice, Nude | 2 | 2008 | 72 |
Why?
| Kainic Acid | 2 | 2008 | 17 |
Why?
| Heart Transplantation | 2 | 2007 | 44 |
Why?
| Complement System Proteins | 2 | 2007 | 30 |
Why?
| Signal Transduction | 3 | 2008 | 313 |
Why?
| Disease Models, Animal | 2 | 2009 | 349 |
Why?
| Nitric Oxide Synthase Type III | 5 | 2004 | 31 |
Why?
| Immunohistochemistry | 2 | 2002 | 355 |
Why?
| Nitric Oxide Synthase | 4 | 2004 | 44 |
Why?
| Secretory Vesicles | 2 | 2008 | 3 |
Why?
| Lectins, C-Type | 1 | 2011 | 19 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 224 |
Why?
| Communicable Diseases | 1 | 2011 | 22 |
Why?
| Chemokine CXCL9 | 1 | 2011 | 5 |
Why?
| Plasmodium berghei | 1 | 2011 | 5 |
Why?
| SNARE Proteins | 3 | 2003 | 3 |
Why?
| Antibodies, Antiphospholipid | 1 | 2010 | 5 |
Why?
| Chemotaxis, Leukocyte | 1 | 2011 | 23 |
Why?
| Thromboxanes | 1 | 2010 | 7 |
Why?
| Mice, Inbred A | 1 | 2010 | 15 |
Why?
| Up-Regulation | 2 | 2005 | 183 |
Why?
| Translational Medical Research | 1 | 2010 | 20 |
Why?
| Valproic Acid | 1 | 2010 | 26 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2008 | 41 |
Why?
| CD40 Ligand | 1 | 2010 | 51 |
Why?
| Graft Survival | 1 | 2010 | 74 |
Why?
| Blood-Brain Barrier | 1 | 2011 | 63 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2009 | 27 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 51 |
Why?
| Down-Regulation | 1 | 2010 | 150 |
Why?
| Aldosterone | 1 | 2009 | 14 |
Why?
| Leukocyte Rolling | 2 | 2005 | 5 |
Why?
| Organ Transplantation | 1 | 2008 | 14 |
Why?
| Peptide Fragments | 3 | 2003 | 144 |
Why?
| Wnt Proteins | 1 | 2009 | 24 |
Why?
| Hemorrhage | 1 | 2010 | 103 |
Why?
| Interferon-gamma | 1 | 2010 | 133 |
Why?
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2008 | 4 |
Why?
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2008 | 8 |
Why?
| Molecular Probes | 1 | 2007 | 17 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2004 | 210 |
Why?
| Cell Movement | 1 | 2010 | 163 |
Why?
| Ion Transport | 1 | 2008 | 42 |
Why?
| Gene Targeting | 1 | 2007 | 51 |
Why?
| Immunoglobulin G | 2 | 2003 | 191 |
Why?
| Biological Assay | 1 | 2008 | 58 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2008 | 38 |
Why?
| Histocompatibility Antigens Class I | 1 | 2008 | 32 |
Why?
| Models, Animal | 1 | 2008 | 85 |
Why?
| Erythrocytes | 1 | 2008 | 109 |
Why?
| Sodium | 1 | 2008 | 96 |
Why?
| Recombinant Fusion Proteins | 2 | 2004 | 189 |
Why?
| Membrane Potentials | 1 | 2008 | 99 |
Why?
| Genotype | 1 | 2007 | 175 |
Why?
| Dendritic Cells | 1 | 2007 | 60 |
Why?
| Cells, Cultured | 7 | 2003 | 447 |
Why?
| Mice, Inbred BALB C | 1 | 2008 | 176 |
Why?
| Coronary Vessels | 1 | 2007 | 53 |
Why?
| Cytokines | 1 | 2010 | 207 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2003 | 94 |
Why?
| Antibodies | 1 | 2007 | 159 |
Why?
| Male | 6 | 2000 | 1553 |
Why?
| Receptors, Leukocyte-Adhesion | 1 | 2005 | 2 |
Why?
| Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2005 | 2 |
Why?
| Peritoneal Cavity | 1 | 2005 | 28 |
Why?
| Venules | 1 | 2005 | 6 |
Why?
| Cyclic GMP | 1 | 2005 | 30 |
Why?
| Ceramides | 1 | 2004 | 13 |
Why?
| Sphingosine | 1 | 2004 | 16 |
Why?
| Gene Products, tat | 1 | 2004 | 13 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 34 |
Why?
| Hydrogen Peroxide | 1 | 2005 | 75 |
Why?
| HIV-1 | 1 | 2010 | 93 |
Why?
| Egtazic Acid | 1 | 2004 | 28 |
Why?
| Lysophospholipids | 1 | 2004 | 19 |
Why?
| Escherichia coli | 1 | 2007 | 143 |
Why?
| Stem Cells | 1 | 2007 | 107 |
Why?
| HIV Infections | 1 | 2010 | 136 |
Why?
| Aorta | 4 | 2003 | 69 |
Why?
| B-Lymphocytes | 1 | 2007 | 134 |
Why?
| Chromogranins | 1 | 2002 | 4 |
Why?
| Chromogranin A | 1 | 2002 | 8 |
Why?
| Cholecystectomy | 1 | 2002 | 16 |
Why?
| Genes, Tumor Suppressor | 1 | 2003 | 37 |
Why?
| Fatal Outcome | 1 | 2002 | 86 |
Why?
| Microscopy, Electron | 1 | 2002 | 178 |
Why?
| Dogs | 1 | 2002 | 159 |
Why?
| Embryonic Development | 1 | 2000 | 26 |
Why?
| Myocardial Infarction | 1 | 2005 | 129 |
Why?
| Carrier Proteins | 1 | 2003 | 177 |
Why?
| Thrombin | 3 | 2003 | 41 |
Why?
| Cell Adhesion | 2 | 2008 | 113 |
Why?
| Transcription Factors | 1 | 2003 | 201 |
Why?
| Gene Expression | 1 | 2000 | 291 |
Why?
| Calcium | 3 | 2004 | 208 |
Why?
| Neoplasms | 1 | 2003 | 239 |
Why?
| Calcium Signaling | 2 | 2004 | 52 |
Why?
| NG-Nitroarginine Methyl Ester | 2 | 2003 | 23 |
Why?
| von Willebrand Factor | 2 | 2003 | 34 |
Why?
| Cysteine | 2 | 2003 | 52 |
Why?
| Female | 4 | 2000 | 1643 |
Why?
| beta 2-Glycoprotein I | 1 | 2010 | 4 |
Why?
| Protein Phosphatase 2 | 1 | 2010 | 15 |
Why?
| LDL-Receptor Related Proteins | 1 | 2010 | 7 |
Why?
| Solubility | 1 | 2010 | 75 |
Why?
| Gene Expression Regulation | 2 | 2003 | 277 |
Why?
| Frizzled Receptors | 1 | 2009 | 3 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2010 | 26 |
Why?
| Wnt3A Protein | 1 | 2009 | 3 |
Why?
| Dimerization | 1 | 2010 | 92 |
Why?
| Wnt3 Protein | 1 | 2009 | 8 |
Why?
| Platelet Adhesiveness | 1 | 2009 | 7 |
Why?
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2009 | 13 |
Why?
| Complement Activation | 1 | 2009 | 13 |
Why?
| rhoA GTP-Binding Protein | 1 | 2009 | 11 |
Why?
| Immunity, Humoral | 1 | 2009 | 12 |
Why?
| AIDS Dementia Complex | 1 | 2010 | 24 |
Why?
| RNA, Small Interfering | 1 | 2010 | 116 |
Why?
| Receptors, Mineralocorticoid | 1 | 2009 | 8 |
Why?
| Cattle | 1 | 2010 | 176 |
Why?
| Pilot Projects | 1 | 2010 | 264 |
Why?
| Protein Structure, Tertiary | 1 | 2010 | 163 |
Why?
| beta Catenin | 1 | 2009 | 34 |
Why?
| Vesicle-Associated Membrane Protein 3 | 1 | 2008 | 2 |
Why?
| Qa-SNARE Proteins | 1 | 2008 | 4 |
Why?
| Microscopy, Video | 1 | 2008 | 8 |
Why?
| Molecular Sequence Data | 2 | 2003 | 404 |
Why?
| HeLa Cells | 1 | 2009 | 107 |
Why?
| HL-60 Cells | 1 | 2008 | 28 |
Why?
| Immunoprecipitation | 1 | 2008 | 57 |
Why?
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2008 | 15 |
Why?
| Enzyme Activation | 1 | 2009 | 177 |
Why?
| Oligonucleotides | 1 | 2007 | 35 |
Why?
| Cell Separation | 1 | 2008 | 110 |
Why?
| P-Selectin | 1 | 2005 | 20 |
Why?
| Simvastatin | 1 | 2005 | 9 |
Why?
| Feedback, Physiological | 1 | 2005 | 26 |
Why?
| Neutrophil Infiltration | 1 | 2005 | 17 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2005 | 39 |
Why?
| Bleeding Time | 1 | 2004 | 10 |
Why?
| Flow Cytometry | 1 | 2008 | 216 |
Why?
| Models, Biological | 1 | 2010 | 410 |
Why?
| Protein Transport | 1 | 2005 | 101 |
Why?
| Macromolecular Substances | 1 | 2005 | 92 |
Why?
| Sphingomyelin Phosphodiesterase | 1 | 2004 | 9 |
Why?
| Phospholipase C gamma | 1 | 2004 | 17 |
Why?
| Oxidation-Reduction | 1 | 2005 | 124 |
Why?
| Desipramine | 1 | 2004 | 20 |
Why?
| Type C Phospholipases | 1 | 2004 | 34 |
Why?
| Interleukin-8 | 1 | 2004 | 54 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 58 |
Why?
| Ribonuclease, Pancreatic | 1 | 2003 | 7 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 67 |
Why?
| Sulfites | 1 | 2003 | 7 |
Why?
| Blotting, Southern | 1 | 2003 | 69 |
Why?
| DNA Methylation | 1 | 2003 | 29 |
Why?
| Adenosine Triphosphate | 1 | 2005 | 121 |
Why?
| Homozygote | 1 | 2003 | 68 |
Why?
| Gene Silencing | 1 | 2003 | 32 |
Why?
| Heterozygote | 1 | 2003 | 80 |
Why?
| Syndrome | 1 | 2003 | 142 |
Why?
| Immunoenzyme Techniques | 1 | 2003 | 125 |
Why?
| Mutagenesis, Site-Directed | 1 | 2003 | 126 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 113 |
Why?
| Protein-Serine-Threonine Kinases | 1 | 2004 | 105 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 216 |
Why?
| Gene Transfer Techniques | 1 | 2003 | 59 |
Why?
| Rabbits | 1 | 2003 | 252 |
Why?
| RNA, Messenger | 1 | 2009 | 394 |
Why?
| Clinical Trials as Topic | 1 | 2005 | 251 |
Why?
| Amino Acid Sequence | 1 | 2004 | 319 |
Why?
| Kinetics | 1 | 2004 | 349 |
Why?
| Dose-Response Relationship, Drug | 1 | 2004 | 431 |
Why?
| Sex Factors | 1 | 2003 | 284 |
Why?
| Recombinant Proteins | 1 | 2003 | 290 |
Why?
| Expressed Sequence Tags | 1 | 2000 | 13 |
Why?
| Time Factors | 1 | 2008 | 896 |
Why?
| Polymerase Chain Reaction | 1 | 2003 | 279 |
Why?
| Gene Library | 1 | 2000 | 50 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 188 |
Why?
| Chromosome Mapping | 1 | 2000 | 107 |
Why?
| DNA, Complementary | 1 | 2000 | 139 |
Why?
| Membrane Proteins | 1 | 2003 | 233 |
Why?
| Mutation | 1 | 2005 | 340 |
Why?
| Pregnancy | 1 | 2000 | 455 |
Why?
|
|
Morrell's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
